Perlich Irene
Insider CIK 1989954 · NGM Principal Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 20,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 7,500 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 30,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 17,500 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 35,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2024-04-05 | 2024-04-08 | 50,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | U Tender | 2024-04-05 | 2024-04-08 | 6,284 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | F Tax w/h | 2024-01-16 | 2024-01-18 | 1,025 | $1.34 | $1.4K | 8,975 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 50,000 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 17,500 | — | $0 | 0 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | A Award deriv | 2023-11-06 | 2023-11-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| NGM NGM BIOPHARMACEUTICALS INC | D To issuer deriv | 2023-11-06 | 2023-11-08 | 35,000 | — | $0 | 0 | SEC↗ |